Antidiabetic drugs after the University Group Diabetes Program (UGDP).
D000138:Acidosis / Q000139:chemically induced; D001645:Biguanides / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004347:Drug Interactions; D006439:Hemodynamics / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects; D007773:Lactates; D010629:Phenformin / Q000378:metabolism / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000494:pharmacology
D001645:Biguanides; D007004:Hypoglycemic Agents; D007773:Lactates; D013453:Sulfonylurea Compounds; D010629:Phenformin